Amyloid Angiopathy Criteria The Next Generation Pdf: Download Cerebral

The Boston criteria version 2.0 for cerebral amyloid angiopathy

: While lobar intracerebral hemorrhage (ICH) and microbleeds remain central, cortical superficial siderosis (cSS) and convexity subarachnoid hemorrhage are now prioritized. Multiple separate foci of siderosis can now qualify a patient for a "probable CAA" diagnosis on their own. The Boston criteria version 2

: Specific patterns of white matter damage. Clinical Significance Clinical Significance : For the first time, white

: For the first time, white matter characteristics are part of the formal criteria. A diagnosis of probable CAA can now be made with just one lobar hemorrhagic lesion if accompanied by either: The "next generation" of cerebral amyloid angiopathy (CAA)

The v2.0 criteria significantly increase diagnostic sensitivity—capturing more true cases without losing specificity—by broadening the biological markers recognized by MRI.

: Enlarged fluid spaces in the deep white matter.

The "next generation" of cerebral amyloid angiopathy (CAA) diagnosis is defined by the , released in late 2022 to replace the 2010 modified criteria. This update shifts the diagnostic paradigm from purely hemorrhagic markers to a more holistic "small vessel disease" profile, integrating white matter signatures. Key Evolutions in the Next Generation Criteria